Tackling Quality—It's Never a Level Playing Field
Companion Piece to the Neurology Outcome Measure Set
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received June 3, 2021
- Accepted December 29, 2021
- First Published January 20, 2022.
Article Versions
- Previous version (January 20, 2022 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Brian Cabaniss, MD,
- Korwyn Williams, MD, PhD,
- Meghan Ward, MD,
- Desiree Cremeen, MA and
- Kavita Nair, PhD
- Brian Cabaniss, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Role: Principal Investigator IRB00090291 Study Title: Stereotactic Laser Ablation for Temporal Lobe Epilepsy (SLATE) Principal Investigator: Brian T. Cabaniss 2020 - Present FTE: 2.5 - 5% Role: Principal Investigator United Health Sciences / Takeda / Emory EEG Earbud Study Title: EEG Earbude Principal Investigator: Brian T. Cabaniss 2019 - Present FTE: 5% Role: Co-investigator NINDS R21 (NS104953) Study Title: Novel Strategies for Mapping the Emotional Neural Circuitry Using Human Brain Stimulation Principal Investigator: Kelly Bijanki and Jon Willie 2018 Â 2020 FTE: 5%
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Korwyn Williams, MD, PhD,
NONE
NONE
American Academy of Neurology for talks on coding.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Meghan Ward, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Compassionate Use Board, Utah Medical Cannabis Program, Utah Department of Health, (2) Utah Labor Commission, (3) RVS Update Committee (RUC), American Academy of Neurology
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Desiree Cremeen, MA and
NONE
NONE
NONE
NONE
NONE
NONE
American Academy of Neurology, Payer Relations and Coverage Program Manager, 2 years
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Kavita Nair, PhD
NONE
NONE
Commercial or non profit entity American Academy of Neurology- Speaking honoraria and travel Consortium of Multiple Sclerosis Centers-Speaking honoraria and travel
NONE
NONE
NONE
NONE
Commercial entity Bristol Meyers Squibb Novartis Genentech Biogen
Commercial Sanofi Genzyme
NONE
NONE
Commercial entity Novartis Genentech Alexion
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Emory University (BC), Atlanta, GA; Phoenix Children's Hospital (KW), Phoenix, AZ; Intermountain Medical Group (MW), Murray, UT; American Academy of Neurology (DC), Minneapolis, MN; and University of Colorado Anschutz Medical Campus (KN), Aurora, CO.
- Correspondence
Dr. Cabaniss brian.t.cabaniss{at}emory.edu
Article usage
The Nerve!: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Daniel Friedman and Dr. Sharon Chiang
► Watch
Related Articles
- No related articles found.